FIELD: organic chemistry, biochemistry, medicine.
SUBSTANCE: invention relates to derivatives of 2-aminonicotine amide of the formula (I): , to methods of their synthesis and a pharmaceutical composition based on thereof inhibiting activity of receptor tyrosine kinase vessel endothelial growth factor (VEGF) and to corresponding method for inhibition of activity of VEGF-receptor tyrosine kinase. It is suggested that this activity will allow offering the curative effect in proliferative diseases associated with angiogenesis, in particular, in treatment of tumors, retinopathy or age degeneration of yellow (corneal) spot.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
9 cl, 42 ex
Title | Year | Author | Number |
---|---|---|---|
ANTHRANILIC ACID AND THIOANTHRANILIC ACID N-ARYLAMIDES | 1999 |
|
RU2286338C2 |
TYROSINE KINASE INHIBITORS | 2008 |
|
RU2445309C2 |
APPLICATION OF PYRIMIDYLAMINOBENZAMIDES FOR TREATMENT OF DISEASES SENSITIVE TO MODULATION OF KINASE Tie-2 ACTIVITY | 2006 |
|
RU2404776C2 |
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND mTOR KINASE INHIBITOR | 2006 |
|
RU2443418C2 |
USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR TREATING SYSTEMIC MASTOCYTOSIS | 2006 |
|
RU2445960C2 |
COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND IMANITIB DERIVATIVES FOR TREATMENT OR PREVENTION OF PROLIFERATIVE DISEASES | 2006 |
|
RU2430727C2 |
PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR NEUROFIBROMATOSIS | 2006 |
|
RU2450814C2 |
CYCLIC THIO-SUBSTITUTED DERIVATIVES OF ACYLAMINO ACID AMIDE AND METHOD OF THEIR SYNTHESIS | 1998 |
|
RU2193556C2 |
N-PHENYL-2-PYRIMIDINE DERIVATIVES | 2003 |
|
RU2370493C2 |
Authors
Dates
2007-03-27—Published
2001-01-25—Filed